281 related articles for article (PubMed ID: 15731042)
21. Effect of coiled-coil peptides on the function of the type III secretion system-dependent activity of enterohemorragic Escherichia coli O157:H7 and Citrobacter rodentium.
Larzábal M; Zotta E; Ibarra C; Rabinovitz BC; Vilte DA; Mercado EC; Cataldi Á
Int J Med Microbiol; 2013 Jan; 303(1):9-15. PubMed ID: 23312797
[TBL] [Abstract][Full Text] [Related]
22. Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.
Girard F; Crepin VF; Frankel G
Infect Immun; 2009 Apr; 77(4):1304-14. PubMed ID: 19188355
[TBL] [Abstract][Full Text] [Related]
23. Comparison of an espB gene fecal polymerase chain reaction assay with bacteriologic isolation for detection of Citrobacter rodentium infection in mice.
McKeel R; Douris N; Foley PL; Feldman SH
Comp Med; 2002 Oct; 52(5):439-44. PubMed ID: 12405637
[TBL] [Abstract][Full Text] [Related]
24. Direct and indirect control of Lrp on LEE pathogenicity genes of Citrobacter rodentium.
Cordone A; Lucchini S; De Felice M; Ricca E
FEMS Microbiol Lett; 2011 Dec; 325(1):64-70. PubMed ID: 22092863
[TBL] [Abstract][Full Text] [Related]
25. Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella.
Jones SE; Knight KL
Infect Immun; 2012 Feb; 80(2):710-9. PubMed ID: 22144475
[TBL] [Abstract][Full Text] [Related]
26. Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium.
Wei OL; Hilliard A; Kalman D; Sherman M
Infect Immun; 2005 Apr; 73(4):1978-85. PubMed ID: 15784538
[TBL] [Abstract][Full Text] [Related]
27. Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice.
Skinn AC; Vergnolle N; Zamuner SR; Wallace JL; Cellars L; MacNaughton WK; Sherman PM
Can J Physiol Pharmacol; 2006 Dec; 84(12):1301-12. PubMed ID: 17487239
[TBL] [Abstract][Full Text] [Related]
28. Intestinal Epithelial Cells and the Microbiome Undergo Swift Reprogramming at the Inception of Colonic Citrobacter rodentium Infection.
Hopkins EGD; Roumeliotis TI; Mullineaux-Sanders C; Choudhary JS; Frankel G
mBio; 2019 Apr; 10(2):. PubMed ID: 30940698
[TBL] [Abstract][Full Text] [Related]
29. Role of class 1 serine protease autotransporter in the pathogenesis of Citrobacter rodentium colitis.
Vijayakumar V; Santiago A; Smith R; Smith M; Robins-Browne RM; Nataro JP; Ruiz-Perez F
Infect Immun; 2014 Jun; 82(6):2626-36. PubMed ID: 24711562
[TBL] [Abstract][Full Text] [Related]
30. The Ethanolamine-Sensing Transcription Factor EutR Promotes Virulence and Transmission during Citrobacter rodentium Intestinal Infection.
Rowley CA; Sauder AB; Kendall MM
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631916
[TBL] [Abstract][Full Text] [Related]
31. Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection.
Vallance BA; Deng W; Knodler LA; Finlay BB
Infect Immun; 2002 Apr; 70(4):2070-81. PubMed ID: 11895973
[TBL] [Abstract][Full Text] [Related]
32. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.
Deng W; Yu HB; de Hoog CL; Stoynov N; Li Y; Foster LJ; Finlay BB
Mol Cell Proteomics; 2012 Sep; 11(9):692-709. PubMed ID: 22661456
[TBL] [Abstract][Full Text] [Related]
33. Citrobacter rodentium of mice and man.
Mundy R; MacDonald TT; Dougan G; Frankel G; Wiles S
Cell Microbiol; 2005 Dec; 7(12):1697-706. PubMed ID: 16309456
[TBL] [Abstract][Full Text] [Related]
34. Activity of Lymphostatin, A Lymphocyte Inhibitory Virulence Factor of Pathogenic Escherichia coli, is Dependent on a Cysteine Protease Motif.
Bease AG; Blackburn EA; Chintoan-Uta C; Webb S; Cassady-Cain RL; Stevens MP
J Mol Biol; 2021 Sep; 433(19):167200. PubMed ID: 34400181
[TBL] [Abstract][Full Text] [Related]
35. Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attaching-effacing lesions.
Wine E; Shen-Tu G; Gareau MG; Goldberg HA; Licht C; Ngan BY; Sorensen ES; Greenaway J; Sodek J; Zohar R; Sherman PM
Am J Pathol; 2010 Sep; 177(3):1320-32. PubMed ID: 20651246
[TBL] [Abstract][Full Text] [Related]
36. Long-term selenium deficiency increases the pathogenicity of a Citrobacter rodentium infection in mice.
Smith AD; Cheung L; Botero S
Biol Trace Elem Res; 2011 Dec; 144(1-3):965-82. PubMed ID: 21584659
[TBL] [Abstract][Full Text] [Related]
37. CD3⁻NK1.1⁺ cells aid in the early induction of a Th1 response to an attaching and effacing enteric pathogen.
Reid-Yu SA; Small CL; Coombes BK
Eur J Immunol; 2013 Oct; 43(10):2638-49. PubMed ID: 23775576
[TBL] [Abstract][Full Text] [Related]
38. Bacillus subtilis spores reduce susceptibility to Citrobacter rodentium-mediated enteropathy in a mouse model.
D'Arienzo R; Maurano F; Mazzarella G; Luongo D; Stefanile R; Ricca E; Rossi M
Res Microbiol; 2006 Nov; 157(9):891-7. PubMed ID: 17005378
[TBL] [Abstract][Full Text] [Related]
39. Modulation of host cytoskeleton function by the enteropathogenic Escherichia coli and Citrobacter rodentium effector protein EspG.
Hardwidge PR; Deng W; Vallance BA; Rodriguez-Escudero I; Cid VJ; Molina M; Finlay BB
Infect Immun; 2005 May; 73(5):2586-94. PubMed ID: 15845460
[TBL] [Abstract][Full Text] [Related]
40. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium.
Wiles S; Clare S; Harker J; Huett A; Young D; Dougan G; Frankel G
Cell Microbiol; 2004 Oct; 6(10):963-72. PubMed ID: 15339271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
